Cargando…
Hepatic carcinoma expressing inhibin: case report of a proposed novel entity and review of the literature
Hepatic carcinoma expressing inhibin is a recently described neoplasm with varied architecture, including trabecular, pseudoglandular, follicular/microcystic, organoid, solid and tubular patterns of growth. We report a case of hepatic carcinoma expressing inhibin that occurred in a 47-year-old woman...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Pathologists/The Korean Society for Cytopathology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288896/ https://www.ncbi.nlm.nih.gov/pubmed/35698738 http://dx.doi.org/10.4132/jptm.2022.04.07 |
_version_ | 1784748550070992896 |
---|---|
author | Syrnioti, Antonia Athanasiou, Evangelia Hytiroglou, Prodromos |
author_facet | Syrnioti, Antonia Athanasiou, Evangelia Hytiroglou, Prodromos |
author_sort | Syrnioti, Antonia |
collection | PubMed |
description | Hepatic carcinoma expressing inhibin is a recently described neoplasm with varied architecture, including trabecular, pseudoglandular, follicular/microcystic, organoid, solid and tubular patterns of growth. We report a case of hepatic carcinoma expressing inhibin that occurred in a 47-year-old woman presenting with epigastric and back pain. The tumor was located in the left hepatic lobe and measured 12 cm in diameter. On immunohistochemical stains, the neoplastic cells were positive for inhibin, as well as cytokeratins 7, 8/18 and 19. There was mild focal expression of synaptophysin, and lack of expression of hepatocytic markers. The histogenesis of hepatic carcinoma expressing inhibin is presently uncertain. From a practical point of view, this neoplasm can potentially cause diagnostic pitfalls by simulating other primary or metastatic tumors, such as hepatocellular carcinoma, cholangiocarcinoma, neuroendocrine tumors, and follicular carcinoma of thyroid gland. Performing inhibin immunostain could assist in the differential diagnosis of liver tumors with unusual histologic features. |
format | Online Article Text |
id | pubmed-9288896 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Korean Society of Pathologists/The Korean Society for Cytopathology |
record_format | MEDLINE/PubMed |
spelling | pubmed-92888962022-07-29 Hepatic carcinoma expressing inhibin: case report of a proposed novel entity and review of the literature Syrnioti, Antonia Athanasiou, Evangelia Hytiroglou, Prodromos J Pathol Transl Med Case Study Hepatic carcinoma expressing inhibin is a recently described neoplasm with varied architecture, including trabecular, pseudoglandular, follicular/microcystic, organoid, solid and tubular patterns of growth. We report a case of hepatic carcinoma expressing inhibin that occurred in a 47-year-old woman presenting with epigastric and back pain. The tumor was located in the left hepatic lobe and measured 12 cm in diameter. On immunohistochemical stains, the neoplastic cells were positive for inhibin, as well as cytokeratins 7, 8/18 and 19. There was mild focal expression of synaptophysin, and lack of expression of hepatocytic markers. The histogenesis of hepatic carcinoma expressing inhibin is presently uncertain. From a practical point of view, this neoplasm can potentially cause diagnostic pitfalls by simulating other primary or metastatic tumors, such as hepatocellular carcinoma, cholangiocarcinoma, neuroendocrine tumors, and follicular carcinoma of thyroid gland. Performing inhibin immunostain could assist in the differential diagnosis of liver tumors with unusual histologic features. The Korean Society of Pathologists/The Korean Society for Cytopathology 2022-07 2022-06-15 /pmc/articles/PMC9288896/ /pubmed/35698738 http://dx.doi.org/10.4132/jptm.2022.04.07 Text en © 2022 The Korean Society of Pathologists/The Korean Society for Cytopathology https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Study Syrnioti, Antonia Athanasiou, Evangelia Hytiroglou, Prodromos Hepatic carcinoma expressing inhibin: case report of a proposed novel entity and review of the literature |
title | Hepatic carcinoma expressing inhibin: case report of a proposed novel entity and review of the literature |
title_full | Hepatic carcinoma expressing inhibin: case report of a proposed novel entity and review of the literature |
title_fullStr | Hepatic carcinoma expressing inhibin: case report of a proposed novel entity and review of the literature |
title_full_unstemmed | Hepatic carcinoma expressing inhibin: case report of a proposed novel entity and review of the literature |
title_short | Hepatic carcinoma expressing inhibin: case report of a proposed novel entity and review of the literature |
title_sort | hepatic carcinoma expressing inhibin: case report of a proposed novel entity and review of the literature |
topic | Case Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288896/ https://www.ncbi.nlm.nih.gov/pubmed/35698738 http://dx.doi.org/10.4132/jptm.2022.04.07 |
work_keys_str_mv | AT syrniotiantonia hepaticcarcinomaexpressinginhibincasereportofaproposednovelentityandreviewoftheliterature AT athanasiouevangelia hepaticcarcinomaexpressinginhibincasereportofaproposednovelentityandreviewoftheliterature AT hytiroglouprodromos hepaticcarcinomaexpressinginhibincasereportofaproposednovelentityandreviewoftheliterature |